DEL MAR – Bright Peak Therapeutics, a company focused on developing immunotherapies in category with few big players, has raised $90 million from venture capitalists. Launched in 2020 and backed by Versant Ventures, Bright Peak’s goal is to build out its portfolio of immunotherapies that can help treat patients with cancer and autoimmune disease. The […]
↧